E-ISSN: 2452-3364
ISSN: 2651-4532
Assessment of the efficiency of Brentuximab Vedotin in patients with pulmonary Hodgkin Lymphoma by the mean of neutrophil to lymphocyte ratio
PDF
Atıf
Paylaş
Talep
Original research article
CİLT: 4 SAYI: 1
P: 29 - 34
2018
Assessment of the efficiency of Brentuximab Vedotin in patients with pulmonary Hodgkin Lymphoma by the mean of neutrophil to lymphocyte ratio
J Oncol Sci 2018;4(1):29-34
DOI:
10.1016/j.jons.2017.10.006
Gokhan Erdem
1
Nuri Karadurmus
2
Sukru Ozaydin
2
Ibrahim Demirci
3
Bilgin Bahadir Basgoz
4
Ismail Ertürk
2
Birol Yıldız
2
Ramzan Ocal
5
Fikret Arpaci
1
Yazar Bilgileri
Telif Hakkı & Lisans Bilgileri
Galenos & J Oncol Sci Açıklama
1.
Liv Hospital, Department of Medical Oncology, Ankara, Turkey
2.
University of Health Sciences, Gulhane Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey
3.
University of Health Sciences, Gulhane Training and Research Hospital, Department of Endocrinology, Ankara, Turkey
4.
University of Health Sciences, Gulhane Training and Research Hospital, Department of Internal Medicine, Ankara, Turkey
5.
Gazi University, Department of Hematology, Ankara, Turkey
Bilgi mevcut değil.
Bilgi mevcut değil
Alındığı Tarih:
2017-01-02
Kabul Tarihi:
2017-10-27
Online Tarih:
0000-00-00
PDF
Atıf
Paylaş
Talep